← Back to Search

Personalized Feedback Intervention for Alcohol Consumption (Project ACE Trial)

N/A

Waitlist Available

Led By Jason Ramirez, PhD

Research Sponsored by University of Washington

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Between ages 18-24

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3-month

Awards & highlights

Project ACE Trial Summary

This trial aims to develop an online intervention to reduce high-risk alcohol use among young adults who drink alcohol. The intervention compares scores before and after viewing/smelling an alcoholic beverage, and provides psycho-educational strategies to reduce drinking desires.

Who is the study for?

This trial is for young adults aged 18-24 in Washington state who drink alcohol at least twice a week and have had one heavy drinking episode recently. They should be open to changing their drinking habits and able to visit the Seattle study office.Check my eligibility

What is being tested?

The study tests a brief online intervention that gives personalized feedback on participants' reactions to alcohol cues, like desire and mood changes after seeing or smelling an alcoholic beverage, compared with those not receiving this feedback.See study design

What are the potential side effects?

Since this is a psychological intervention focusing on providing feedback rather than medication, traditional physical side effects are not expected. However, discussing alcohol use could cause discomfort or emotional responses.

Project ACE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 24 years old.

Project ACE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3-month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3-month

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Brief Young Adult Alcohol Consequences Questionnaire

Daily Drinking Questionnaire

Penn Alcohol Craving Scale

Project ACE Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Lab-based Cue Reactivity Personalized Feedback Intervention (PFI)Experimental Treatment1 Intervention

Participants randomized to the Lab-based Cue Reactivity PFI condition will receive a link to the personalized feedback in the lab after completing the cue reactivity protocol. Participants view the feedback on their own during the lab session. The personalized feedback is delivered online and contains information summarizing participants' desire to drink, mood, willingness to drink, and alcohol demand as reported before and after alcohol exposure.

Group II: Assessment-only controlActive Control1 Intervention

Participants randomized to the control group will not receive any intervention. They complete all the survey assessments and the lab-based cue reactivity protocol without ever receiving any personalized feedback.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Lab-based Cue Reactivity Personalized Feedback Intervention (PFI)

2023

N/A

~120

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH

807 Previous Clinical Trials

1,157,969 Total Patients Enrolled

University of WashingtonLead Sponsor

1,747 Previous Clinical Trials

1,847,262 Total Patients Enrolled

Jason Ramirez, PhDPrincipal InvestigatorUniversity of Washington

1 Previous Clinical Trials

101 Total Patients Enrolled

Media Library

Lab-based Cue Reactivity Personalized Feedback Intervention (PFI) Clinical Trial Eligibility Overview. Trial Name: NCT05873556 — N/A

Alcohol Consumption Research Study Groups: Lab-based Cue Reactivity Personalized Feedback Intervention (PFI), Assessment-only control

Alcohol Consumption Clinical Trial 2023: Lab-based Cue Reactivity Personalized Feedback Intervention (PFI) Highlights & Side Effects. Trial Name: NCT05873556 — N/A

Lab-based Cue Reactivity Personalized Feedback Intervention (PFI) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05873556 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could I potentially qualify for this experiment?

"Prerequisites for this trial include a documented alcohol use disorder and an age between 18 to 24 years. This study requires the recruitment of exactly 100 participants."

Answered by AI

Is there an age restriction for participants in this research?

"The parameters of the study necessitate that candidates are between 18-24 years old. In comparison, there are 20 studies limited to minors and 177 studies mainly targeting seniors."

Answered by AI

Are participants currently being sought for this testing program?

"The information on clinicaltrials.gov verifies that this trial is actively recruiting participants, beginning from 8th May 2023 and last updated 15th May 2023."

Answered by AI

What is the estimated participant capacity for this medical research?

"Yes, according to clinicaltrials.gov, the investigation is still in search of participants and has been since May 8th 2023. The study was last edited on May 15th 2023 and requires a total of 100 individuals at one site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Testing Brief Personalized Feedback Integrating Lab-based Alcohol Cue Information

Jason Ramirez 2023. "Testing Brief Personalized Feedback Integrating Lab-based Alcohol Cue Information". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05873556.